Rett Syndrome
Rett syndrome is a rare X-linked neurodevelopmental disorder caused by pathogenic MECP2 mutations. After normal early development, affected girls experience regression with loss of purposeful hand skills, impaired communication, autonomic dysfunction, and motor abnormalities. Boys with similar mutations often present with severe neonatal encephalopathy.
Clinical Features
- Normal development until 6–18 months followed by regression
- Loss of purposeful hand use, development of stereotypic hand wringing/washing
- Deceleration of head growth (acquired microcephaly)
- Gait abnormalities, ataxia, apraxia
- Severe speech impairment
- Breathing irregularities (hyperventilation, breath-holding), seizure risk
- Autonomic dysfunction, scoliosis, constipation, GERD, sleep problems
Diagnosis
- Clinical criteria + MECP2 genetic testing (found in >95% classic cases)
- Exclude other causes of regression (metabolic, neurodegenerative)
- CDKL5 or FOXG1 mutations produce Rett-like phenotypes
- EEG and MRI supportive but not diagnostic
Multidisciplinary Management
- Medication: trofinetide (FDA-approved) improves behavior and communication in young girls; antiseizure meds tailored to seizures; medications for spasticity, reflux, constipation, sleep
- Therapies: physical/occupational therapy, speech therapy with augmentative communication devices, music therapy
- Orthopedic: monitor for scoliosis, hip dysplasia, contractures; bracing or surgery as needed
- Nutrition: high-calorie diets, feeding therapy; gastrostomy for safety or weight gain
- Respiratory: manage apnea, hyperventilation, and aspiration risk; consider CPAP/BiPAP
- Cardiology: monitor for prolonged QTc
- Behavioral & Mental Health: support for mood, anxiety, caregiver burden
Living with Rett Syndrome
- Track milestones, seizures, breathing events, sleep quality, GI symptoms, therapies, equipment needs
- Ensure adaptive seating, communication devices, accessible transportation
- Transition planning for adolescence/adulthood (menstrual management, bone health, vocational programs)
- Support networks (International Rett Syndrome Foundation) provide education and respite options
Complications
- Seizures, aspiration pneumonia, scoliosis progression
- Osteopenia and fractures
- Autonomic instability (arrhythmias)
- Growth failure, nutritional deficiencies
Research & Future Directions
Gene therapy, RNA editing, and MECP2 reactivation are top priorities. Trials explore AVV-based MECP2 delivery, X-reactivation strategies, and drugs modulating downstream pathways (BDNF, IGF-1).
Experimental & Emerging Treatments
- Gene Therapy (MECP2 Replacement): AVV.rh10-based therapies (TSHA-102) in early-phase trials.
- Gene Reactivation: XIST-targeted approaches to flip on the silenced MECP2 allele.
- RNA Editing: CRISPR base editors correcting recurrent nonsense mutations.
- Neurotrophic Modulators: Compounds enhancing BDNF or IGF-1 to improve synaptic function.
Track Rett Syndrome with Diagnoza.care
Coordinate Care Across Disciplines – Log developmental milestones/regression, seizures, breathing episodes, trofinetide dosing, therapies, nutrition, orthopedic checkups, sleep studies, and specialist visits; capture side effects & equipment needs; and let the AI companion remind caregivers of follow-ups and new trial opportunities.
Medical Disclaimer: Informational only. Work with your Rett specialty clinic for genetic counseling, medication decisions, interdisciplinary therapy, and clinical trial enrollment.
Sources: International Rett Syndrome Foundation, National Institutes of Health, American Academy of Pediatrics